ArticleNeuroscience2026
Impact of 5-HT7 receptor gene deletion on memory and affective behaviors in young and aged mice.
Article in Neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Histone Deacetylase Inhibitors Improve Memory Function and Decrease Neuropathology in APP/PS1 Mice.Research square · 2026Article
- Serotonergic System Dysregulation in Alzheimer's Disease.ACS chemical neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The 5-HT7 receptor subtype is expressed throughout the brain, including the cortex and hippocampus, and it has been implicated in the molecular mechanisms underlying memory and affective behaviors. Although aging also affects memory and behavior, how 5-HT7 receptor interacts with age-related changes of these phenotypes has not been fully elucidated. To further understand the role of 5-HT7 receptor on memory and affective behaviors across the lifespan, we assessed age-related changes in locomotor activity, spatial and recognition memory, sociability, anxiety- and depression-like behaviors in young (3-month-old) and aged (24-month-old) 5-HT7 receptor gene knockout (5-HT7 OK) and wild-type (WT) mice. Additionally, the mRNA expression levels of the htr7, htr1a, and htr2a in the cortex and hippocampus were determined using qPCR. Results indicated that 5-HT7 KO impaired short-time spatial memory and sociability, with more pronounced deficits in the aged group. Depression-like behavior was reduced in young and aged 5-HT7 KO mice, suggesting deletion of 5-HT7 receptor gene may involve an antidepressant-like effect. In the cortex, there was no differences in htr7 expression were observed between young and aged WT mice, and no differences in htr1a and htr2a expression across genotype groups. However, in the hippocampus, there was a significant reduced htr7 expression in aged WT mice and significant decreased htr1a and htr2a expression in aged 5-HT7 KO mice. Our results suggest that 5-HT7 signaling plays an important role in regulating spatial memory, social and affective behaviors during aging, highlighting its potential as a therapeutic target for age-related neuropsychiatric and neurodegenerative disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.